Test Retest Reproducibility of Organ Volume Measurements in ADPKD Using 3D Multimodality Deep Learning

Xinzi He1,2, Zhongxiu Hu2, Hreedi Dev2, Dominick J. Romano2, Arman Sharbatdaran2, Syed I. Raza2, Sophie J. Wang2, Kurt Teichman2, George Shih2, James M. Chevalier3,4, Daniil Shimonov3,4, Jon D. Blumenfeld3,4, Akshay Goel2, Mert R. Sabuncu1,2, Martin R. Prince2,5
1School of Electrical and Computer Engineering, Cornell University and Cornell Tech, New York, New York (X.H., R.S.)
2Department of Radiology, Weill Cornell Medicine, New York, New York (X.H., Z.H., H.D., D.J.R., A.S., S.I.R., S.J.W., K.T., G.S., A.G., R.S., M.R.P.)
3Department of Medicine, Weill Cornell Medicine, New York, New York (J.M.C., D.S., J.D.B.)
4The Rogosin Institute, New York, New York (J.M.C., D.S., J.D.B.)
5Columbia University Vagelos College of Physicians and Surgeons, New York, New York (M.R.P.)

Tài liệu tham khảo

Grantham, 2016, The importance of total kidney volume in evaluating progression of polycystic kidney disease, Nat Rev Nephrol, 12, 667, 10.1038/nrneph.2016.135 Chapman, 2012, Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease, Clin J Am Soc Nephrol, 7, 479, 10.2215/CJN.09500911 Torres, 2016, Effect of tolvaptan in autosomal dominant polycystic kidney disease by CKD stage: results from the TEMPO 3:4 trial, Clin J Am Soc Nephrol, 11, 803, 10.2215/CJN.06300615 Torres, 2017, Tolvaptan in later-stage autosomal dominant polycystic kidney disease, N Engl J Med, 377, 1930, 10.1056/NEJMoa1710030 Irazabal, 2015, Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials, J Am Soc Nephrol, 26, 160 Demoulin, 2021, Limited performance of estimated total kidney volume for follow-up of ADPKD, Kidney Int Rep, 6, 2821, 10.1016/j.ekir.2021.08.013 Sharma, 2017, Kidney volume measurement methods for clinical studies on autosomal dominant polycystic kidney disease, PLoS ONE, 12, 10.1371/journal.pone.0178488 Sharbatdaran, 2022, Deep learning automation of kidney, liver, and spleen segmentation for organ volume measurements in autosomal dominant polycystic kidney disease, Tomography, 8, 1804, 10.3390/tomography8040152 van Gastel, 2019, Automatic measurement of kidney and liver volumes from MR images of patients affected by autosomal dominant polycystic kidney disease, J Am Soc Nephrol, 30, 1514 Kline, 2017, Performance of an artificial multi-observer deep neural network for fully automated segmentation of polycystic kidneys, J Digit Imaging, 30, 442, 10.1007/s10278-017-9978-1 Kim, 2016, Automated segmentation of kidneys from MR images in patients with autosomal dominant polycystic kidney disease, Clin J Am Soc Nephrol, 11, 576, 10.2215/CJN.08300815 Jagtap, 2022, Automated measurement of total kidney volume from 3D ultrasound images of patients affected by polycystic kidney disease and comparison to MR measurements, Abdom Radiol, 47, 2408, 10.1007/s00261-022-03521-5 Goel, 2022, Deployed deep learning kidney segmentation for polycystic kidney disease MRI, Radiol Artif Intell, 4, 10.1148/ryai.210205 Raj, 2022, Deep learning-based total kidney volume segmentation in autosomal dominant polycystic kidney disease using attention, cosine loss, and sharpness aware minimization, Diagnostics, 12, 1159, 10.3390/diagnostics12051159 Mu, 2019, Automatic MR kidney segmentation for autosomal dominant polycystic kidney disease, Proc. SPIE, 10950 Taylor, 2022, MO012: development of an accurate automated segmentation algorithm to measure total kidney volume in ADPKD suitable for clinical application (the cystvas study), Nephrol Dialysis Transplant, 37 Keshwani D., Kitamura Y., Li Y. Computation of Total Kidney Volume from CT images in Autosomal Dominant Polycystic Kidney Disease using Multi-Task 3D Convolutional Neural Networks. arXiv 2018. Onthoni, 2020, Deep learning assisted localization of polycystic kidney on contrast-enhanced CT images, Diagnostics, 10, 1113, 10.3390/diagnostics10121113 Shin, 2020, Expert-level segmentation using deep learning for volumetry of polycystic kidney and liver, Investig Clin Urol, 61, 555, 10.4111/icu.20200086 Hsiao, 2022, A deep learning-based precision and automatic kidney segmentation system using efficient feature pyramid networks in computed tomography images, Comput Methods Programs Biomed, 221 Potretzke, 2023, Clinical implementation of an artificial intelligence algorithm for magnetic resonance–derived measurement of total kidney volume, Mayo Clin Proc, 98, 689, 10.1016/j.mayocp.2022.12.019 Dev, 2023, Effect of averaging measurements from multiple MRI pulse sequences on kidney volume reproducibility in autosomal dominant polycystic kidney disease, J Magn Reson Imaging, 58, 1153, 10.1002/jmri.28593 Zhu, 2023, Clinical quality control of MRI total kidney volume measurements in autosomal dominant polycystic kidney disease, Tomography, 9, 1341, 10.3390/tomography9040107 Yin, 2019, Spleen phenotype in autosomal dominant polycystic kidney disease, Clinical Radiology, 74, 975.e917, 10.1016/j.crad.2019.08.015 Isensee, 2021, nnU-Net: a self-configuring method for deep learning-based biomedical image segmentation, Nat Methods, 18, 203, 10.1038/s41592-020-01008-z Zhang, 2019, Relationship of seminal megavesicles, prostate median cysts, and genotype in autosomal dominant polycystic kidney disease, J Magn Reson Imaging, 49, 894, 10.1002/jmri.26289 Farooq, 2017, Complex liver cysts in autosomal dominant polycystic kidney disease, Clin Imaging, 46, 98, 10.1016/j.clinimag.2017.07.014 Liu, 2023, Pleural effusions on MRI in autosomal dominant polycystic kidney disease, J Clin Med, 12, 386, 10.3390/jcm12010386 Kim, 2015, Seminal vesicles in autosomal dominant polycystic kidney disease, Codon Publications, 443 Deng J., Dong W., Socher R., et al. ImageNet: A large-scale hierarchical image database. In Proceedings of IEEE Conference on Computer Vision and Pattern Recognition, Florida, USA, 18 Aug 2009. Ronneberger, 2015, U-Net: convolutional networks for biomedical image segmentation, arXiv Zhang, 2015, Deep learning with elastic averaging SGD, arXiv Edwards, 2021, Automated total kidney volume measurements in pre-clinical magnetic resonance imaging for resourcing imaging data, annotations, and source code, Kidney Int, 99, 763, 10.1016/j.kint.2020.07.040 Zöllner, 2012, Assessment of kidney volumes from MRI: acquisition and segmentation techniques, Am J Roentgenol, 199, 1060, 10.2214/AJR.12.8657 van Gastel, 2018, T1 vs. T2 weighted magnetic resonance imaging to assess total kidney volume in patients with autosomal dominant polycystic kidney disease, Abdom Radiol, 43, 1215, 10.1007/s00261-017-1285-2 Torres, 2012, Tolvaptan in patients with autosomal dominant polycystic kidney disease, N Engl J Med, 367, 2407, 10.1056/NEJMoa1205511 Bae, 2009, MRI-based kidney volume measurements in ADPKD: reliability and effect of gadolinium enhancement, Clin J Am Soc Nephrol, 4, 719, 10.2215/CJN.03750708 Riyahi, 2021, Hemorrhagic cysts and other MR biomarkers for predicting renal dysfunction progression in autosomal dominant polycystic kidney disease, J Magn Reson Imaging, 53, 564, 10.1002/jmri.27360 Kline, 2017, Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease, Kidney Int, 92, 1206, 10.1016/j.kint.2017.03.026 Karner, 2022, Cyst fraction as a biomarker in autosomal dominant polycystic kidney disease, J Clin Med, 12, 326, 10.3390/jcm12010326